Pfizer Raises Its Guidance and Analysts Up Their Targets - PFE Stock Looks Cheap

Pfizer, Inc. (PFE) stock is incredibly cheap following management's raise of its 2025 adjusted earnings per share guidance. It's at just over 8x this year's estimates and 7.8x next year. That's too cheap. Shorting out-of-the-money (OTM) put options works here.

PFE is at $24.59 today, up slightly from before its Aug. 5 earnings release. I discussed how statistically cheap PFE was in my July 29 Barchart article ("Pfizer Stock Is a Value Play Ahead of Earnings - Investors Can Short PFE Puts for Income").